Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Sanders VA, Cutler CS. Radioarsenic: A promising theragnostic candidate for nuclear medicine. Nucl Med Biol 2020;92:184-201. [PMID: 32376084 DOI: 10.1016/j.nucmedbio.2020.03.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 03/18/2020] [Indexed: 10/24/2022]

For:	Sanders VA, Cutler CS. Radioarsenic: A promising theragnostic candidate for nuclear medicine. Nucl Med Biol 2020;92:184-201. [PMID: 32376084 DOI: 10.1016/j.nucmedbio.2020.03.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Accepted: 03/18/2020] [Indexed: 10/24/2022]

Number

Cited by Other Article(s)

Ma L, Grant C, Gallazzi F, Watkinson LD, Carmack TL, Embree MF, Smith CJ, Medvedev D, Cutler CS, Li Y, Wilbur DS, Hennkens HM, Jurisson SS. Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2. Nucl Med Biol 2022;108-109:61-69. [DOI: 10.1016/j.nucmedbio.2022.03.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2021] [Revised: 02/26/2022] [Accepted: 03/11/2022] [Indexed: 02/07/2023]

Benešová M, Reischl G. Production of radionuclides: Cyclotrons and reactors. Nucl Med Mol Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00003-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open

Naskar N, Lahiri S. Separation of no-carrier-added 71,72As from 46 MeV alpha particle irradiated gallium oxide target. RADIOCHIM ACTA 2021. [DOI: 10.1515/ract-2020-0120] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]